More than 100 million people worldwide are affected by diabetes, but many are undiagnosed. This number will increase to 300 million people by year 2025, according to the World Health Organization (WHO). At least 80% of these cases are type 2 diabetes, or Non-Insulin Dependent Diabetes Mellitus (NIDDM). This occurs fairly late in life, typically at 50 years or higher, although the age of onset is decreasing. Risk factors are unhealthy food intake and lack of exercise.
PerkinElmer Life Sciences offers two AutoDELFIA kits mainly for use in type 2 diabetes, Insulin and C-peptide. While glucose testing is used for diagnosing type 2 diabetes, insulin and C-peptide testing are used in further investigations. PerkinElmer Life Sciences also offers research products for the investigation of type 1 diabetes (Insulin Dependent Diabetes Mellitus IDDM).
The availability of PerkinElmer Genetic Screening products varies between countries. For products available in the USA please select the category ending "- in USA" , and for products available outside the USA select the category ending "- outside USA".